About
Contact & Profiles
A5081432472
Research Areas
- Pneumocystis jirovecii pneumonia detection and treatment
- HIV/AIDS drug development and treatment
- HIV Research and Treatment
- Inflammasome and immune disorders
- Long-Term Effects of COVID-19
- Diabetes and associated disorders
- COVID-19 Clinical Research Studies
- HIV-related health complications and treatments
- HIV/AIDS Research and Interventions
Hospital General Universitario de Elche
2022
Background The pathophysiology of long-COVID remains unknown, and information is particularly limited for symptoms very long duration. We aimed to assess the serological, T-cell immune responses ANA titers patients with long-COVID-19 syndrome 1-year Methods Prospective, longitudinal study hospitalized COVID-19 followed-up 12 months. Sequential blood samples symptom questionnaires (CSQ) were obtained, humoral cellular responses, antinuclear antibodies (ANA) inflammation biomarkers analyzed....
10.3389/fimmu.2022.920627
article
EN
cc-by
Frontiers in Immunology
2022-08-24
Coming Soon ...